AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (3.4 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Characterization and Efficacy of A Novel Formula of Insulin Chitosan Layered Duple Hydroxide-Nanohybrid for Oral Administration

Ahmed Abdel-Wahab El-Shahawy1Adel Abdel-Moneim2( )Zienab Esam Eldin3Ahmed Ismail Youssef2Zhraa Selem Gouda2Hanaa Ramadan2Eiman Amar2Esraa Ashraf Taha2Asmaa Mohamed Saied2Mohamed Zanaty4
Department of Materials Science and Nanotechnology, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Egypt
Division of Molecular Physiology, Faculty of Science, Beni-Suef University, Egypt
Faculty of Veterinary Medicine, Beni-Suef University, Egypt
Department of Biotechnology, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Egypt
Show Author Information

Abstract

The development of an oral insulin therapy remains an ultimate goal to both enhance ease of use, and to provide therapeutic advantages rooted in its direct delivery to the portal vein and liver. The current study aimed to develop a novel formula for insulin oral administration against experimental diabetes in rats. Entrapped insulin (INS) between chitosan nanoparticles (CSNPs) and layered duple hydroxide (LDH) (LDH-INS-CSNPs) was chemically prepared, and characterized by X-ray diffraction, Fourier transformation infrared, high-resolution transmission electron microscope, field emission scanning electron microscope and Zeta potential measurements. The insulin release study was conducted in vitro, while the oral hypoglycemic effect of LDH-INS-CSNPs was investigated in vivo in diabetic rats. The prepared formulas revealed a variation in the spectra of characterization methods. The insulin entrapment between LDH and chitosan avoided the burst release of insulin and acid denaturation in the stomach and enzymatic degradation throughout the gut. Consequently, the blood glucose level of LDH-INS-CSNPs formula exhibited a marked hypoglycemic effect. The present work showed that the LDH-INS-CSNPs formula had a protective effect against enzymatic degradation, reduced insulin initial burst release, and enhanced bioavailability through the oral administration route. Interestingly, the presented formula could be an oral antidiabetic agent alternative to injectable insulin.

References

[1]

O. Korsgren, B. Nilsson, Improving islet transplantation: A road map for a widespread application for the cure of persons with type I diabetes. Curr Opin Organ Tran, 2009, 14: 683-687.

[2]

Y.Y. Luo, X.Y. Xiong, Y. Tian, et al., A review of biodegradable polymeric systems for oral insulin delivery. Drug Deliv, 2016, 23(6): 1882-1891.

[3]

K. Al Rubeaan, M. Rafiullah, and S. Jayavanth, Oral insulin delivery systems using chitosan-based formulation: a review. Expert Opin Drug Deliv, 2016, 13(2): 223-237.

[4]

S. Gupta, A. Jain, M. Chakraborty, et al., Oral delivery of therapeutic proteins and peptides: a review on recent developments. Drug Deliv, 2013, 20: 237-246.

[5]

P. Li, H.M. Nielsen, and M. Fano, A. Müllertz, Preparation and characterization of insulin-surfactant complexes for loading into lipid-based drug delivery systems. J Pharm Sci., 2013, 102: 2689-2698.

[6]

X. Zhao, C. Shan, Y. Zu, et al., Preparation, characterization, and evaluation in vivo of Ins-SiO(2)-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin. Int J Pharm, 2013, 454: 278-284.

[7]

M. Werle, B. Loretz, D. Entstrasser, et al., Design and evaluation of a chitosan-aprotinin conjugate for the peroral delivery of therapeutic peptides and proteins susceptible to enzymatic degradation, J Drug Target, 2007, 15: 327-333.

[8]

Y. Zhang, W. Wei, P. Lv, et al., Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin. Eur J Pharm Biopharm, 2011, 77: 11-19.

[9]

J. Li, C. Cai, J. Li, et al., Chitosan-Based Nanomaterials for Drug Delivery. Molecules, 2018, 23(10): 2661. doi: 10.3390/molecules23102661

[10]

C. Saikia, P. Gogoi, and T.K. Maji, Chitosan: A Promising Biopolymer in Drug Delivery Applications. J Mol Genet Med, 2015, S4: 006. doi: 10.4172/1747-0862.S4-006.

[11]

J. Lin, Y. Li, Y. Li, et al., Drug/Dye-loaded, multifunctional PEG-chitosan-iron oxide nanocomposites for methotraxate synergistically self-targeted cancer therapy and dual model imaging. ACS Appl Mater Interfaces, 2015, 7: 11908-11920.

[12]

A. Ravindran-Girija, and S. Balasubramanian., Theragnostic potentials of core/shell mesoporous silica nanostructures. Nanotheranostics, 2019, 3(1): 1-40.

[13]

Li Y, Liu D, Ai H, et al., Biological evaluation of layered double hydroxides as efficient drug vehicles. Nanotechnology, 2010, 21(10): 105101.

[14]

K. Zhang, Z.P. Xu, J. Lu, et al., Potential for layered double hydroxides-based, innovative drug delivery systems. Int J Mol Sci, 2014, 15(5): 7409-7428.

[15]

L.P.F. Benício, R.A. Silva, J.A. Lopes, et al., Layered double hydroxides: Nanomaterials for applications in agriculture. Rev Bras Ciênc Solo, 2015, 39: 1-13.

[16]
D. Hwan, P. Goeun, and C. Ho-Choy., Bio-layered double hydroxides nanohybrids for theranostics applications. Photofunctional layered materials (structure and bonding), 2015th edition, Springer, 2015: 137-175.
[17]

E.B. Souto, S.B. Souto, J.R. Campos, et al., Nanoparticle delivery systems in the treatment of diabetes complications. Molecules., 2019, 20;24(23): 4209.

[18]

Y. Yang, H. Zhu, J. Wang, et al., Enzymatically disulfide crosslinked chitosan/hyaluronic acid layer-by-layer self-assembledmicrocapsules for redox-responsive controlled release of protein. ACS Appl Mater Interfaces, 2018, 10: 33493-33506.

[19]

N. Tajuddin, J. Manayil, M. Isaacs, et al., Alkali-free Zn-Al layered double hydroxide catalysts for triglyceride transesterification. Catalysts, 2018, 8 (12): 667.

[20]

P.R. Wei, S.H. Cheng, W.N. Liao, et al., Synthesis of chitosan-coated near-infrared layered double hydroxide nanoparticles for in vivo optical imaging. J Mater Chem, 2012, 22: 5503-5513.

[21]

N.K. Al-Nemrawi, S.M. Alsharif, K.H. Alzoubi, et al., Preparation and characterization of insulin chitosan-nanoparticles loaded in buccal films. Pharm Dev Technol, 2019, 24(8): 967-974.

[22]

K. Divya1, and M.S. Jisha., Chitosan nanoparticles preparation and applications. Environ Chem Lett, 2018, 16: 101-112.

[23]

P. Zhao, Y. Liu, L. Xiao, H. Deng, Y. Du, and X. Shi, Electrochemical deposition to construct nature inspired multilayer chitosan/layered double hydroxides hybrid gel for stimuli responsive release of protein. J Mater Chem B, 2015, 3(38): 7577-7584.

[24]

F. Cui1, L. Zhang, J. Zheng, et al., A study of insulin-chitosan complex nanoparticles used for oral administration. J Drug Del Sci Tsch, 2004, 14(6): 435-439.

[25]

F.G. Soufi, D. Mohammad-Nejad, and H. Ahmadieh, Resveratrol improves diabetic retinopathy possibly through oxidative stress-nuclear factor κB-apoptosis pathway. Pharmacol Rep, 2012, 64(6): 1505-1514.

[26]

A.R. Sotiles, N.A.G. Gomez, S.C. Silva, et al., Layered Double Hydroxides with the Composition Mn/Al-SO4-A (A=Li, Na, K; Mn: Al ca.1:1) as Cation Exchangers. J Braz Chem Soc, 2019, 30(9): 1807-1813.

[27]

B. Balcomb, M. Singh, and S. Singh., Synthesis and characterization of layered double hydroxides and their potential as nonviral gene delivery vehicles. Open Chem J, 2015, 4(2): 137-145.

[28]

D. Sokol, DEL Vieira, A. Zarkov, et al., Sonication accelerated formation of Mg-Al-phosphate layered double hydroxide via sol-gel prepared mixed metal oxides. Scientific Reports, 2019, 9: 10419. https://doi.org/10.1038/s41598-019-46910-5.

[29]

R.C. Zeng, X.T. Li, Z.G. Liu, et al., Corrosion resistance of Zn-Al layered double hydroxide/poly(lactic acid) composite coating on magnesium alloy AZ31. Front Mater Sci, 2015, 9(4): 355-365.

[30]

T. Qi, B.J. Reddy, H. He, et al., Synthesis and infrared spectroscopic characterization of selected layered double hydroxides containing divalent Ni and Co. Mater Chem Phys, 2008, 112(3): 869-875.

[31]

S. Babakhani, Z.A. Talib, M.Z. Hussein, et al., Optical and thermal properties of Zn/Al-layered double hydroxide nanocomposite intercalated with sodium dodecyl sulfate. J Spectrosc, 2014, 2014: 467064.

[32]

N.A. Mohamed, and N.A. Abd El-Ghany., Synthesis and antimicrobial activity of some novel terephthaloyl thiourea cross-linked carboxymethyl chitosan hydrogels. Cellulose, 2012, 19: 1879-1891.

[33]

L. Nielsen, S. Frokjaer, J.F. Carpenter, et al., Studies of the structure of insulin fibrils by Fourier transform infrared (FTIR) spectroscopy and electron microscopy. J Pharm Sci, 2001, 90(1): 29-37.

[34]

G. Sharma, A.R. Sharma, J.S. Nam, et al., Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes. J Nanobiotechnology, 2015, 13: 74. doi:10.1186/s12951-015-0136-y.

[35]

H. Iyer, A. Khedkar, and M. Verma., Oral insulin- a review of current status. Diabetes Obes Metab, 2010, 12: 179-185.

[36]

N.G. Schipper, K.M. Vârum, P. Stenberg, et al., Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement. Eur J Pharm Sci, 1999, 8(4): 335-343.

[37]

N. Saïed, and M. Aïder., Zeta Potential and Turbidimetry Analyzes for the evaluation of chitosan/phytic acid complex formation. J Food Res, 2014, 3(2): 71-81.

[38]

Y. Shao, L. Li, X. Gu, et al., Evaluation of chitosan–anionic polymers based tablets for extended-release of highly water-soluble drugs, Asian J Pharm Sci, 2015, 10(1): 24-30.

[39]

M.A. Mohammed, J.T.M. Syeda, K.M. Wasan, et al. An overview of chitosan nanoparticles and its application in non-parenteral drug delivery, Pharmaceutics, 2017, 9: 53.

[40]

J.O.Y. Mathew, S.J. Iyengar, J. Chakraborty, and S. Ghosh. Layered double hydroxide using hydrothermal treatment: morphology evolution, intercalation and release kinetics of diclofenac sodium. Front Mater Sci. 2017, 11(4): 395-409.

[41]

B.J. Bruno, G.D. Miller, and C.S. Lim., Basics and recent advances in peptide and protein drug delivery. Ther Deliv, 2013, 4(11): 1443-1467.

[42]

H. Liu, W.S. Pan, R. Du, et al., Effects of protease inhibitors on intestinal absorption of insulin. Yao Xue Xue Bao, 2004, 39(2): 140-143.

Nano Biomedicine and Engineering
Pages 297-305
Cite this article:
Abdel-Wahab El-Shahawy A, Abdel-Moneim A, Esam Eldin Z, et al. Characterization and Efficacy of A Novel Formula of Insulin Chitosan Layered Duple Hydroxide-Nanohybrid for Oral Administration. Nano Biomedicine and Engineering, 2020, 12(4): 297-305. https://doi.org/10.5101/nbe.v12i4.p297-305

702

Views

44

Downloads

2

Crossref

3

Scopus

Altmetrics

Received: 23 May 2020
Accepted: 01 September 2020
Published: 23 October 2020
© Ahmed El-Shahawy, Adel Abdel-Moneim, Zienab Eldin, Ahmed Youssef, Zhraa Gouda, Hanaa Ramadan, Eiman Amar, Esraa Taha, Asmaa Saied, and Mohamed Zanaty.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return